This week in gene and cell therapy - 24 May 2019

Gene and cell therapy headlines 20 May - 24 May

Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy

Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products

bluebird bio to Present New Data from Clinical Studies of LentiGlobin™ Gene Therapy for Transfusion-Dependent β-thalassemia (TDT) and LentiGlobin Gene Therapy for Sickle Cell Disease (SCD) at the 24th EHA Congress

Genetically Personalized Fruit Flies Screen for Cancer Drugs

Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II